Own the Future of Care.

Invest in companies tackling the world's biggest medical challenges.

The ROBO Global Healthcare Technology & Innovation ETF (HTEC) provides differentiated healthcare exposure by focusing on innovators in the space. 

VIEW FUND DETAILS
SCHEDULE TIME WITH OUR TEAM

EXPERTISE

5

Strategic advisors, including PhDs and tech visionaries

THOUGHTFUL DIVERSIFICATION

60+

Companies in healthcare technology and innovation

ESTABLISHED

6

Years of track record

HEALTHCARE IS AT THE BEGINNING OF A TECHNOLOGY-DRIVEN REVOLUTION

The convergence of robotics, AI, and life sciences is driving breakthrough advancements across all of healthcare. Though adoption is still in its earliest stages, systemic changes are just around the corner.

We believe this revolution will profoundly transform the healthcare industry. Innovation creates profit opportunities for some businesses while commoditization places margin pressure on others. 

The emerging winners are those companies that effectively deploy innovations such as AI, genomics, precision medicine, robotics, and automation to improve the quality of care while simultaneously reducing costs

DOWNLOAD THE INVESTMENT CASE
HTEC Investment Case Image - MockUp - STUDY04

UNMET NEEDS ARE DRIVING HEALTHCARE INNOVATION GLOBALLY

The healthcare industry is undergoing a fundamental transformation as society shifts from reactive sick care to proactive preventative care. With chronic disease prevention offering unprecedented cost savings opportunities and technological advances enabling personalized medicine at scale, we believe healthcare is experiencing one of the most significant paradigm shifts in its history.
 

Shift to Prevention

Reorienting healthcare systems away from treating illness toward preventing disease through AI-powered monitoring and early intervention.

Automation & Robotic Solutions

Advanced technologies deployed across the ecosystem improving safety, accuracy, and productivity while also addressing provider shortages.

Personalized Medicine

Genomic science, precision medicine, and advanced analytics enabling tailored treatments for every patient's unique health situation.

A RESEARCH-DRIVEN APPROACH

The ROBO index construction process is advised by several world-renowned experts in robotics and artificial intelligence, including four PhD specialists in their field.

Daniela_Rus_Background (1)

Daniela Rus, PhD

Professor at MIT, Director of CSAIL Research Center
Henrik_Christensen_Background (1)

Henrik Christensen, PhD

Professor at UC San Diego, Director of Contextual Robotics Institute
illah-1

Illah Nourbakhsh, PhD

Professor of Robotics, Director of CREATE Lab, Carnegie Mellon
Morten_Paulsen

Morten Paulsen

Head of Research and Managing Director
CLSA Japan
Wyatt_Newman_Background (1)

Wyatt Newman, PhD

Professor of Humanoid Robotics & AI, 10+ Patents, 130 Publications

ETF PERFORMANCE

HTEC Growth 7.1.26

Fund Inception Date 06/25/2019

6.48%
ANNUALIZED RETURN SINCE INCEPTION (as of 6/25/2019)
$60M
TOTAL AUM
62
HOLDINGS

 

Data as of 6/30/26

Performance data quoted represents past performance and is no guarantee of future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than the original cost. Current performance may be lower or higher than the original cost. Returns for periods of less than one year are not annualized. For standard performance as of the most recent month-end and current holdings, please click here. 

Ready to Invest in Healthcare Innovation?

Get access to companies we believe are revolutionizing healthcare
through technology and innovation, creating better outcomes while reducing costs.

MEET WITH OUR TEAMREGISTER FOR OUR NEXT VIRTUAL EVENT